NovoSeven Summary
				n Currently off-label for trauma / CT Surgery n Incidence of serious adverse events <1% n Caution n Elderly n Those with pre-existing thrombotic risk factors n Intra-cranial pathology / surgery n DIC / sepsis
	n Effective in 90 % of cases (case reports) n Not derived from blood n Not antigenic n Effective when other Rx has failed n Unaffected by blood supply shortages